Skip to main content

Segura Dávila, Karen

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Segura Dávila, Karen

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Shirley Guzmán Avilés

Shirley Guzmán Avilés

Gestió i Administració
External Strategy Directorate
Read more
Elisa Marín Ordovás

Elisa Marín Ordovás

Predoctoral researcher
Clinical Neuroimmunology
Read more
Maria Josefa Azpiroz Franch

Maria Josefa Azpiroz Franch

Predoctoral researcher
Cardiovascular Diseases
Read more
Elena Vargas Accarino

Elena Vargas Accarino

Postdoctoral researcher
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.